ArticleAmerican journal of translational research2024

Neuroendocrine prostate cancer drivers SOX2 and BRN2 confer differential responses to imipridones ONC201, ONC206, and ONC212 in prostate cancer cell lines.

Connor Purcell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.